Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership642,687 shares
Latest Disclosed Value $ 880,481
Barclays Plc reports 7.29% increase in ownership of ALLO / Allogene Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 642,687 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $880,481 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 598,997 shares of Allogene Therapeutics, Inc.. This represents a change in shares of 7.29% during the quarter. The current value of the position is $1,311,081 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 642,687 43,690 7.29 880 18.60 0.0002
2026-03-31 2025-09-30 13F/A-3 ALLOGENE THERAPEUTICS COM 019770106 598,997 -46,328 -7.18 743 1.78 0.0002
2026-03-19 2025-09-30 13F/A-2 ALLOGENE THERAPEUTICS COM 019770106 342,973 -302,352 960 0.0003
2025-11-12 2025-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 598,997 -46,328 743 0.0002
2026-02-27 2025-06-30 13F/A-2 ALLOGENE THERAPEUTICS COM 019770106 645,325 -10,066 -1.54 729 -23.74 0.0002
2025-08-14 2025-06-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 645,325 -10,066 1 0.0002
2025-08-13 2025-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 645,325 -10,066 1 0.0001
2026-03-17 2025-03-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 655,391 -105,895 -13.91 957 -41.02 0.0003
2025-05-15 2025-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 655,391 -105,895 1 0.0003
2026-03-19 2024-12-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 761,286 418,313 121.97 1,622 68.85 0.0005
2025-02-13 2024-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 761,286 418,313 2 0.0005
2026-03-31 2024-09-30 13F/A-2 ALLOGENE THERAPEUTICS COM 019770106 342,973 172,745 101.48 960 142.42 0.0003
2024-11-19 2024-09-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 342,973 172,745 1 0.0003
2024-11-15 2024-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 342,973 172,745 1 0.0001
2026-03-23 2024-06-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 170,228 13,481 8.60 397 -43.43 0.0001
2024-08-14 2024-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 170,228 13,481 0 0.0001
2026-03-24 2024-03-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 156,747 -28,160 -15.23 701 18.04 0.0002
2024-05-15 2024-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 156,747 -28,160 1 0.0002
2026-03-25 2023-12-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 184,907 -601,886 -76.50 594 -76.22 0.0002
2024-02-15 2023-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 184,907 -601,886 1 0.0002
2026-03-26 2023-09-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 786,793 117,596 17.57 2,494 -24.99 0.0016
2023-11-07 2023-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 786,793 117,596 2 0.0016
2026-03-30 2023-06-30 13F/A-2 ALLOGENE THERAPEUTICS COM 019770106 669,197 168,546 33.67 3,326 34.45 0.0021
2023-09-20 2023-06-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 669,197 168,546 3 0.0021
2023-08-03 2023-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 669,197 168,546 3 0.0021
2026-03-30 2023-03-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 500,651 77,598 18.34 2,473 -7.07 0.0011
2023-05-04 2023-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 500,651 77,598 2 0.0011
2026-03-30 2022-12-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 423,053 105,287 33.13 2,661 -22.47 0.0012
2023-02-13 2022-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 423,053 105,287 3 0.0012
2022-11-03 2022-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 317,766 287,087 935.78 3,432 880.57 0.0037
2022-08-12 2022-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 30,679 -73,692 -70.61 350 -63.20 0.0002
2022-05-16 2022-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 104,371 4,039 4.03 951 -36.47 0.0007
2022-02-23 2021-12-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 100,332 56,582 129.33 1,497 33.19 0.0006
2022-02-14 2021-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 100,332 56,582 1,497 0.0002
2021-11-09 2021-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 43,750 -52,184 -54.40 1,124 -55.09 0.0005
2021-08-13 2021-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 95,934 -33,584 -25.93 2,503 -45.24 0.0012
2021-05-13 2021-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 129,518 68,113 110.92 4,571 194.71 0.0025
2021-02-11 2020-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 61,405 -17,899 -22.57 1,551 -48.14 0.0008
2020-11-12 2020-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 79,304 -9,307 -10.50 2,991 -21.19 0.0018
2020-08-12 2020-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 88,611 26,629 42.96 3,795 215.20 0.0029
2020-05-13 2020-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 61,982 13,896 28.90 1,204 -3.53 0.0010
2020-02-10 2019-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 48,086 16,197 50.79 1,248 43.45 0.0007
2019-11-15 2019-09-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 31,889 6,883 27.53 870 29.66 0.0005
2019-11-14 2019-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 31,889 6,883 870 201.1450
2019-08-14 2019-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 25,006 -5,005 -16.68 671 -22.70 0.0004
2019-05-15 2019-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 30,011 29,027 2,949.90 868 3,114.81 0.0006
2019-02-14 2018-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 984 984 27 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.